These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 3281031)

  • 1. Combined modality approach to treatment of malignant gliomas--re-evaluation of RTOG 7401/ECOG 1374 with long-term follow-up: a joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group.
    Nelson DF; Diener-West M; Horton J; Chang CH; Schoenfeld D; Nelson JS
    NCI Monogr; 1988; (6):279-84. PubMed ID: 3281031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine.
    Selker RG; Shapiro WR; Burger P; Blackwood MS; Arena VC; Gilder JC; Malkin MG; Mealey JJ; Neal JH; Olson J; Robertson JT; Barnett GH; Bloomfield S; Albright R; Hochberg FH; Hiesiger E; Green S;
    Neurosurgery; 2002 Aug; 51(2):343-55; discussion 355-7. PubMed ID: 12182772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality-adjusted survival analysis of malignant glioma. Patients treated with twice-daily radiation (RT) and carmustine: a report of Radiation Therapy Oncology Group (RTOG) 83-02.
    Murray KJ; Nelson DF; Scott C; Fischbach AJ; Porter A; Farnan N; Curran WJ
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):453-9. PubMed ID: 7852106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?
    Nieder C; Andratschke N; Wiedenmann N; Busch R; Grosu AL; Molls M
    Strahlenther Onkol; 2004 Jul; 180(7):401-7. PubMed ID: 15241527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials.
    Buckner JC; Ballman KV; Michalak JC; Burton GV; Cascino TL; Schomberg PJ; Hawkins RB; Scheithauer BW; Sandler HM; Marks RS; O'Fallon JR; ;
    J Clin Oncol; 2006 Aug; 24(24):3871-9. PubMed ID: 16921039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized comparisons of radiotherapy and carmustine versus procarbazine versus dacarbazine for the treatment of malignant gliomas following surgery: a Southwest Oncology Group Study.
    Eyre HJ; Eltringham JR; Gehan EA; Vogel FS; Al-Sarraf M; Talley RW; Costanzi JJ; Athens JW; Oishi N; Fletcher WS
    Cancer Treat Rep; 1986 Sep; 70(9):1085-90. PubMed ID: 3017551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma.
    Tsao MN; Mehta MP; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):47-55. PubMed ID: 16111571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404.
    Prados MD; Seiferheld W; Sandler HM; Buckner JC; Phillips T; Schultz C; Urtasun R; Davis R; Gutin P; Cascino TL; Greenberg HS; Curran WJ
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1147-52. PubMed ID: 15001257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study.
    Chang CH; Horton J; Schoenfeld D; Salazer O; Perez-Tamayo R; Kramer S; Weinstein A; Nelson JS; Tsukada Y
    Cancer; 1983 Sep; 52(6):997-1007. PubMed ID: 6349785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02.
    Werner-Wasik M; Scott CB; Nelson DF; Gaspar LE; Murray KJ; Fischbach JA; Nelson JS; Weinstein AS; Curran WJ
    Cancer; 1996 Apr; 77(8):1535-43. PubMed ID: 8608540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V.
    Michalski JM; Winter K; Purdy JA; Parliament M; Wong H; Perez CA; Roach M; Bosch W; Cox JD
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):706-13. PubMed ID: 15936549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment modalities for malignant gliomas with reference to their pathophysiology].
    Kobayashi S; Takakura K
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):11-7. PubMed ID: 3942392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal treatment for localized esophageal cancer still uncertain.
    Lord RV
    Am J Gastroenterol; 2000 Jan; 95(1):305-7. PubMed ID: 10638607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose BCNU and autologous progenitor cell transplantation given with intra-arterial cisplatinum and simultaneous radiotherapy in the treatment of high-grade gliomas: benefit for selected patients.
    Fernández-Hidalgo OA; Vanaclocha V; Vieitez JM; Aristu JJ; Rebollo J; Gúrpide A; Aramendía JM; Moreno-Palanques R; Martín-Algarra S; Subirá ML; Brugarolas A
    Bone Marrow Transplant; 1996 Jul; 18(1):143-9. PubMed ID: 8832007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas.
    Levin VA; Hess KR; Choucair A; Flynn PJ; Jaeckle KA; Kyritsis AP; Yung WK; Prados MD; Bruner JM; Ictech S; Gleason MJ; Kim HW
    Clin Cancer Res; 2003 Mar; 9(3):981-90. PubMed ID: 12631596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of ACNU alone and combined with tegafur as additions to radiotherapy of the treatment of malignant gliomas--a cooperative clinical trial].
    Ushio Y; Abe H; Suzuki J; Tanaka R; Kitamura K; Miwa T; Matsutani M; Takeuchi K; Takakura K; Nomura K
    No To Shinkei; 1985 Oct; 37(10):999-1006. PubMed ID: 3000412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients.
    Durando X; Lemaire JJ; Tortochaux J; Van-Praagh I; Kwiatkowski F; Vincent C; Bailly C; Verrelle P; Irthum B; Chazal J; Bay JO
    Bone Marrow Transplant; 2003 Apr; 31(7):559-64. PubMed ID: 12692621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.
    Weller M; Müller B; Koch R; Bamberg M; Krauseneck P;
    J Clin Oncol; 2003 Sep; 21(17):3276-84. PubMed ID: 12947063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy in supratentorial gliomas. A study of 821 cases.
    Heesters M; Molenaar W; Go GK
    Strahlenther Onkol; 2003 Sep; 179(9):606-14. PubMed ID: 14628126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial.
    Westphal M; Ram Z; Riddle V; Hilt D; Bortey E;
    Acta Neurochir (Wien); 2006 Mar; 148(3):269-75; discussion 275. PubMed ID: 16482400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.